Your browser doesn't support javascript.
loading
CaMKII-mediated Beclin 1 phosphorylation regulates autophagy that promotes degradation of Id and neuroblastoma cell differentiation.
Li, Xuan; Wu, Xiao-Qi; Deng, Rong; Li, Dan-Dan; Tang, Jun; Chen, Wen-Dan; Chen, Jing-Hong; Ji, Jiao; Jiao, Lin; Jiang, Shan; Yang, Fen; Feng, Gong-Kan; Senthilkumar, Ravichandran; Yue, Fei; Zhang, Hai-Liang; Wu, Rui-Yan; Yu, Yan; Xu, Xue-Lian; Mai, Jia; Li, Zhi-Ling; Peng, Xiao-Dan; Huang, Yun; Huang, Xiang; Ma, Ning-Fang; Tao, Qian; Zeng, Yi-Xin; Zhu, Xiao-Feng.
Afiliación
  • Li X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Wu XQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Deng R; The 3rd Affiliated Hospital, Sun Yat-sen University, 510620, Guangzhou, China.
  • Li DD; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Tang J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Chen WD; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Chen JH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Ji J; Department of Hematology, The Second Affiliated Hospital, Guangzhou Medical University, 510260, Guangzhou, China.
  • Jiao L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Jiang S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Yang F; Department of Oncology, The First Affiliated Hospital, Chongqing Medical University, 400016, Chongqing, China.
  • Feng GK; Department of Biochemistry and Molecular Biology, Nanjing Medical University, 211166, Nanjing, China.
  • Senthilkumar R; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Yue F; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Zhang HL; Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX, 77030, USA.
  • Wu RY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Yu Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Xu XL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Mai J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Li ZL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Peng XD; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Huang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Huang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
  • Ma NF; The School of Medicine, Jinan University, 510632, Guangzhou, China.
  • Tao Q; Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, 511436, Guangzhou, China.
  • Zeng YX; Sir YK Pao Cancer Centre, Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Zhu XF; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, 510060, Guangzhou, China.
Nat Commun ; 8(1): 1159, 2017 10 27.
Article en En | MEDLINE | ID: mdl-29079782
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína 1 Inhibidora de la Diferenciación / Proteína 2 Inhibidora de la Diferenciación / Proteína Quinasa Tipo 2 Dependiente de Calcio Calmodulina / Beclina-1 / Neuroblastoma Límite: Animals / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína 1 Inhibidora de la Diferenciación / Proteína 2 Inhibidora de la Diferenciación / Proteína Quinasa Tipo 2 Dependiente de Calcio Calmodulina / Beclina-1 / Neuroblastoma Límite: Animals / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido